These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29475405)

  • 1. Interstitial pneumonitis and myelosuppression associated to mitomycin C urinary tract instillations: A case report.
    Rodriguez-Reyes M; Marco-Hernandez J; Castro-Rebollo P; Soy-Muner D
    J Oncol Pharm Pract; 2019 Apr; 25(3):739-742. PubMed ID: 29475405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary fibrosis and endovesical mitomycin C].
    Janeiro Pais JM; Casas Agudo VP; López Garcia D; González Dacal J; Lamas Meilán C; González Martín M
    Actas Urol Esp; 2009; 33(7):822-5. PubMed ID: 19757670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical mitomycin-C-induced interstitial pneumonia.
    Wada H; Nakano Y; Yamada H; Saiga T; Yamanaka A; Sakai N
    Respiration; 2010; 80(3):256-9. PubMed ID: 20130385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial pneumonitis: an exceptional toxicity of hyperthermic intraperitoneal mitomycin C.
    González-Moreno S; Lambert LA; Mansfield PF
    Eur J Surg Oncol; 2008 Apr; 34(4):482-4. PubMed ID: 17434283
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug eruption due to intravesical instillations of both epirubicin and mitomycin C.
    Okumura A; Oishi N; Kaji K; Imamura T; Fuse H
    J Dermatol; 2009 Jul; 36(7):419-22. PubMed ID: 19583691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin-induced interstitial pneumonitis in a patient with BRCA2 associated metastatic pancreatic carcinoma.
    Saif MW; Dai T
    JOP; 2010 May; 11(3):277-9. PubMed ID: 20442529
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lung sarcoidosis following instillation of mitomycin C in the urinary bladder].
    Cuervo Pinna MA; Cuervo Pinna C; Macías Castillo S; Bureo Dacal JC; Espada Alonso MJ; Pimentel Leo J
    An Med Interna; 2001 Dec; 18(12):641-3. PubMed ID: 11852501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
    Kleinmann N; Matin SF; Pierorazio PM; Gore JL; Shabsigh A; Hu B; Chamie K; Godoy G; Hubosky S; Rivera M; O'Donnell M; Quek M; Raman JD; Knoedler JJ; Scherr D; Stern J; Weight C; Weizer A; Woods M; Kaimakliotis H; Smith AB; Linehan J; Coleman J; Humphreys MR; Pak R; Lifshitz D; Verni M; Adibi M; Amin MB; Seltzer E; Klein I; Konorty M; Strauss-Ayali D; Hakim G; Schoenberg M; Lerner SP
    Lancet Oncol; 2020 Jun; 21(6):776-785. PubMed ID: 32631491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.
    Matin SF; Pierorazio PM; Kleinmann N; Gore JL; Shabsigh A; Hu B; Chamie K; Godoy G; Hubosky SG; Rivera M; O'Donnell M; Quek M; Raman JD; Knoedler JJ; Scherr D; Weight C; Weizer A; Woods M; Kaimakliotis H; Smith AB; Linehan J; Coleman J; Humphreys MR; Pak R; Lifshitz D; Verni M; Klein I; Konorty M; Strauss-Ayali D; Hakim G; Seltzer E; Schoenberg M; Lerner SP
    J Urol; 2022 Apr; 207(4):779-788. PubMed ID: 34915741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: Safety and feasibility.
    Donin NM; Strauss-Ayali D; Agmon-Gerstein Y; Malchi N; Lenis AT; Holden S; Pantuck AJ; Belldegrun AS; Chamie K
    Urol Oncol; 2017 May; 35(5):272-278. PubMed ID: 28065395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bladder necrosis after an immediate post-operative mitomycin C instillation].
    Branchereau J; Luyckx F; Hitier M; Karam G; Bouchot O; Rigaud J
    Prog Urol; 2011 Feb; 21(2):151-3. PubMed ID: 21296285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).
    O'Brien T; Ray E; Singh R; Coker B; Beard R;
    Eur Urol; 2011 Oct; 60(4):703-10. PubMed ID: 21684068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary results of a randomised phase 2 study.
    Colombo R; Rocchini L; Suardi N; Benigni F; Colciago G; Bettiga A; Pellucchi F; Maccagnano C; Briganti A; Salonia A; Rigatti P; Montorsi F
    Eur Urol; 2012 Nov; 62(5):797-802. PubMed ID: 22633362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer.
    Mostafid AH; Rajkumar RG; Stewart AB; Singh R
    BJU Int; 2006 Mar; 97(3):509-12. PubMed ID: 16469017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic cystitis following immediate post-resection intravesical instillation of mitomycin-C.
    Caso J; Qin D; Sexton WJ
    Can J Urol; 2010 Jun; 17(3):5223-5. PubMed ID: 20566021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected increase in the bone marrow toxicity of mitomycin C (MMC).
    Yoshimoto M; Saito M; Tada T; Kasumi KT
    Br J Cancer; 2001 Mar; 84(5):736-7. PubMed ID: 11237399
    [No Abstract]   [Full Text] [Related]  

  • 19. Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C.
    Racioppi M; Porreca A; Foschi N; Delicato G; Destito A; D'Addessi A
    Urol Int; 2005; 75(4):373-5. PubMed ID: 16327311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marker tumour responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer-Genitourinary Group (EORTC 30897).
    Van der Meijden AP; Hall RR; Macaluso MP; Pawinsky A; Sylvester R; Van Glabbeke M
    Eur Urol; 1996; 29(2):199-203. PubMed ID: 8647147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.